Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Mar;12(4):635-40.
doi: 10.1517/14656566.2011.557661. Epub 2011 Feb 6.

Aripiprazole for the treatment of irritability associated with autism

Cristan Ann Farmer  1 , Michael G Aman
Affiliations
Review

Aripiprazole for the treatment of irritability associated with autism

Cristan Ann Farmer et al. Expert Opin Pharmacother. 2011 Mar.

Abstract

Introduction: Irritability (including tantrums, aggression and moodiness) is often associated with autistic disorder. Children with autism are frequently prescribed atypical antipsychotic medications for these behaviors. Although multiple agents have been found to be effective, the safety and tolerability of each antipsychotic may be the determining factor in its selection.

Areas covered: The pharmacokinetics, pharmacodynamics, safety and efficacy data on aripiprazole for the treatment of irritability associated with autism are discussed. Knowledge of the mechanism of action, advantages and disadvantages relative to other atypical antipsychotics, and an appreciation of the efficacy of aripiprazole when used to treat irritability in autism is also explored in this paper.

Expert opinion: Aripiprazole may have a more favorable side-effect profile than another commonly prescribed medication, risperidone, because of its unique mechanism of action. It seems to be effective in treating irritability associated with autism, but more research is needed.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interest: The second author has been a consultant to and received grant support from Bristol-Myers Squibb, the company that distributes aripiprazole. Additionally, they have been an unpaid consultant and received research support from Johnson & Johnson, which manufactures risperidone (a competitor of aripiprazole).

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4. Washington, DC: American Psychiatric Association; 2000.
    1. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators and Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders—autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMQR Surveill Summ. 2007;56:12–28. - PubMed
    1. Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children: conformation of high prevalence. Am J Psychiatry. 2005;162:1133–1141. - PubMed
    1. Fombonne E, Zakarian R, Bennett A, et al. Pervasive developmental disorders in Montreal, Quebec, Canada: Prevalence and links with immunizations. Pediatrics. 2006;118:e139–e150. - PubMed
    1. Lecavalier L. Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification. J Autism Dev Disord. 2006;36:1101–1114. - PubMed

MeSH terms

LinkOut - more resources